About Dr. Rayaz Ahmed

Dr. Rayaz Ahmed

MBBS, MD Pathology, DM Clinical Haematology

Hematologic Oncologist,Hematologist

19 Years Experience Overall (14 years as specialist)

Clinical Hematologist, Bone Marrow Transplant Physician

Education Details

• MBBS, Pt. Ravi Shanker University, Raipur, C.G. India, 1999
• MD, Shivaji University Kolhapur, Maharashtra, 2003
• DM, Christian Medical College & Hospital, Vellore, Tamil Nadu, 2010

Speciality Interest

• Autologous Stem Cell Transplant
• Allogeneic Stem Cell Transplant (Matched Sibling Donor Stem Cell Transplant)
• Haplo Identical Stem Cell Transplant
• Matched Unrelated Stem Cell Transplant
• Aplastic Anemia
• Thalassemia Treatment
• Sickle Cell Anemia
• Leukemia (AML/ ALL/ CML/CLL)
• Lymphoma (Hodgkin and NonHodgkin)
• Multiple Myeloma

Professional Details

• Experience of 17+ years, more than 1000 bone marrow transplants
• Senior Consultant, Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
• Associate Professor, Department of Hematology, CMC Vellore

Awards

• Successfully Conducted Autologous, Allogeneic (MSD, MUD, Haplo)
• University Gold Medal in MD Pathology 2003, Shivaji University, Kolhapur, Maharashtra

Research Papers & Publications

• Longterm outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children
• Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a crosssectional study
• Vraf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia
• The use of a fludarabinebased conditioning regimen in patients with severe aplastic anemiaa retrospective analysis from three Indian centers
• Two novel missense mutations in iron transport protein transferrin causing hypochromic microcytic anaemia and haemosiderosis: molecular characterization and structural implications
• Outcome of treatment with a low cost protocol in adults with T cell acute lymphoblastic leukemia in a tertiary care center in India
• Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
• Molecular basis of WiskottAldrich syndrome in patients from India
• Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia